Mercado mundial de química clínica: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

Los analizadores de química clínica han ganado cada vez más popularidad en las últimas décadas como resultado de los grandes avances tecnológicos y la creciente demanda de las empresas de atención médica. La química clínica se centra en el examen de los fluidos corporales internos y proporciona información diagnóstica precisa. La química clínica moderna se basa en las pruebas de laboratorio manuales tradicionales. Sin embargo, a medida que la tecnología ha avanzado, se han desarrollado métodos de prueba y ahora se pueden realizar varias pruebas en laboratorios automatizados utilizando dispositivos complejos como los analizadores químicos.

Data Bridge Market Research analiza que el mercado de la química clínica, que era de 13 mil millones de dólares en 2021, se disparará hasta los 19,58 mil millones de dólares en 2029, y se espera que experimente una CAGR del 5,25% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis experto en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

Chemical techniques are used in clinical chemistry to determine the amounts of chemical components in body fluids. It is a branch of biochemistry that deals with the diagnostic evaluation of bodily fluids. Clinical chemistry is used to diagnose diseases, determine metabolic function, and assess the presence of medications by evaluating serum, blood, cerebrospinal fluids, plasma, and urine samples for analyte concentration.

Clinical Chemistry Market Dynamics

Drivers

• Rise in demand of clinical chemistry

In the forecast period of 2022-2029, rising demand for POCT kits and analysers for rapid detection, rising occurrences of cardiovascular disorders, diabetes, hypertension, and others, rising preferences for automated devices, and increasing government initiatives for the prevalence of better healthcare diagnostics facilities are expected to accelerate the growth of the clinical chemistry market. On the other hand, the growing number of research activities will enhance numerous prospects, resulting in the clinical chemistry market growing during the projection period.

• Rise in the geriatric population

The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising healthcare spending, and the fast-growing diagnostic industry drive the worldwide clinical chemistry market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the clinical chemistry market forward.

• Prevalence of chronic ailments

The rise of clinical chemistry has recently been fueled by an increase in the frequency of chronic diseases such as cancer and diabetes, which has resulted in increased demand for faster diagnosis, technological innovations, and scientific research for future therapeutic applications. The developments give benefits such as easy parameter monitoring, automatic data gathering, and automatic variable modifications, to name a few. The whole clinical chemistry market is expected to rise in the future as healthcare and medical professionals need more automated clinical chemistry procedures. In addition, the clinical chemistry business is seeing growing demand due to rising disposable incomes and increased awareness of the need of diagnostic examinations.

Opportunities

The total clinical chemistry market is predicted to grow in the future due to an increased desire for automated clinical chemistry techniques among healthcare and medical professionals. In the coming years, government initiatives and actions to promote clinical chemistry's benefits could potentially help boost the clinical chemistry industry. Growing awareness of the importance of diagnostic tests and rising disposable incomes are driving demand in the clinical chemistry industry.

Restraints/Challenges

Unavailability of skilled professionals along with high cost of devices will hamper the growth of the clinical chemistry market in the mentioned forecast period.

This clinical chemistry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Clinical Chemistry Market

The COVID-19 epidemic had a negative impact on the companies' sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests performed and reagent sales. However, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. With the COVID-19 pandemic, dealing with infectious diseases has become a major medical concern around the world. In addition to vaccinations and therapeutic medications, there is an increasing demand for more precise and simple testing technologies as well as the expansion of testing structures.

Recent Development

• January 2019 – Hofmann-La-Roche Ltd has released COBAS PRO, an integrated solution in the Serum Work Area. This is a big milestone in laboratory diagnostics, as it can perform 2,200 tests every hour.
• February 2019 – Fujifilm Corporation and JEOL have formed a strategic partnership in the international clinical chemistry analyzer market.

Global Clinical Chemistry Market Scope

The clinical chemistry market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Clinical Chemistry Analysers
• POC Test Kits
• Clinical Chemistry Analyser Kits and Reagents

 Application

• Basic Metabolite Panel
• Liver Function Test
• Electrolyte Panel
• Kidney Function Test
• Lipid Profile
• Specialty Chemical Test
• Thyroid Profile
• Other Biochemical Tests

End-User

• Hospitals
• Pathology Laboratories
• Maternity Centres
• Outpatient Centres
• Clinics

Clinical Chemistry Market Regional Analysis/Insights

The clinical chemistry market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.

The countries covered in the clinical chemistry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the clinical chemistry market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness and growing demand for advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Análisis del panorama competitivo y de la cuota de mercado de la química clínica

El panorama competitivo del mercado de la química clínica proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de la química clínica.

Algunos de los principales actores que operan en el mercado de la química clínica son:

• Abbott (Estados Unidos)
• Danaher (Estados Unidos)
• Thermo Fisher Scientific Inc. (Estados Unidos)
• F. Hoffmann-La Roche Ltd. (Suiza)
• Johnson & Johnson Services, Inc. (Estados Unidos)
• Siemens (Alemania)
• Grupo ELI Tech (Francia)
• HORIBA, Ltd. (Japón)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
• Randox Laboratories Ltd. (Reino Unido)
• Diagnóstico clínico de ortodoncia (EE. UU.)
• Nova Biomedical (Estados Unidos)
• Corporación Sysmex (Japón)
• Bio Systems Diagnostics Pvt. Ltd. (India)
• DiaSys Diagnostic Systems GmbH (Alemania)
• Endress Hauser Management AG (Suiza)
• Diatron (Hungría)
• SFRI. (Francia)
• EKF Medica Corporation (Reino Unido)

SKU-53044